|
Volumn 100, Issue , 2002, Pages 215-224
|
Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma
a,b c c c
c
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAZOLAMIDE;
ADRENALIN;
CANNABINOID;
CANNABIS;
CARBACHOL;
DIPIVEFRINE;
DRONABINOL;
ECOTHIOPATE IODIDE;
METHAZOLAMIDE;
PILOCARPINE;
TIMOLOL;
ANTIHYPERTENSIVE AGENT;
TETRAHYDROCANNABINOL;
ADULT;
AGED;
ANXIETY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONFUSION;
DEPRESSION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
INTRAOCULAR PRESSURE;
LASER SURGERY;
MALE;
MEDICAL SPECIALIST;
OPEN ANGLE GLAUCOMA;
PERCEPTION DISORDER;
PRIORITY JOURNAL;
SEDATION;
SIDE EFFECT;
SOMNOLENCE;
TRABECULECTOMY;
UNITED STATES;
VERTIGO;
XEROSTOMIA;
ARTICLE;
DRUG EFFECT;
MIDDLE AGED;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIHYPERTENSIVE AGENTS;
FEMALE;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
TETRAHYDROCANNABINOL;
TREATMENT OUTCOME;
|
EID: 0036988167
PISSN: 00659533
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (45)
|
References (0)
|